Serum levels of dimeric activin A are not a marker of placental tumors in the course of chemotherapy

Journal of Endocrinological Investigation

Volumn 21, Issue 3, 1998, Pages 166-169

  Florio, P ^c   Luisi, S ^c   Casarosa, E ^c   Genazzani, A R ^c   Pautier, P ^a   Lhomme C ^a   Bidart, J M ^a   Driul, P G ^b   Petraglia, F ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITY OF UDINE   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Activin A; Placental tumors

Indexed keywords

ACTIVIN A; ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN; DIMER; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CANCER CHEMOTHERAPY; CHORIOCARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GONADOTROPIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNORADIOMETRIC ASSAY; PLACENTA; PREGNANCY; TROPHOBLASTIC DISEASE;

EID: 0031901090     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347296     Document Type: Article

References (12)

1. Wallace E.M., Healy D.L. Inhibins and activins: roles in clinical practice. Br. J. Obstet. Gynecol. 103: 945, 1996.
2. Petraglia F., Florio P., Nappi C., Genazzani A.R. Peptide signalling in human placenta and fetal membranes: autocrine, paracrine, and endocrine mechanisms. Endocrine Rev. 17: 156, 1996.
3. Abe Y., Hasegawa Y., Miyamoto K., Yamaguchi M., Andoh A., Ibuki Y., Igarashi M. High concentrations of plasma immunoreactive inhibin during normal pregnancy in women. J. Clin. Endocrinol. Metab. 71: 133, 1990.
4. Yohkaichiya T., Fukaya T., Hoshiai H., Yajima A., De Kretser D.M. Inhibin: a new circulating marker of hydatidiform mole? Br. Med. J. 298: 1684, 1989.
5. Badonnel Y., Barbe F., Legagneur H., Poncelet E., Schweitzer M. Inhibin as a marker for hydatidiform mole: a comparative determination of intact human chorionic gonadotrophin and its free beta-subunit. Clin. Endocrinol (Oxf.) 41: 155, 1994.
6. Petraglia F., Rarg S., Florio P., Sadick M., Gallinelli A., Wong W.L., Krummen L., Comitini G., Mather J., Woodruff T.K. Activin A and activin B measured in maternal serum, cord blood serum and in amniotic fluid during human pregnancy. Endocrinol. J. 1: 323, 1993.
7. Muttukrishna S., Fowler P.A., George L., Groome N.P., Knight P.G. Changes in serum levels of total activin A during the human menstrual cycle and pregnancy. J. Clin. Endocrinol. Metab. 81: 3328, 1996.
8. Petraglia F., Gallinelli A., De Vita D., Lewis K., Mathews L., Vale W. Activin at parturition: changes of maternal serum levels and evidence for binding sites in placenta and fetal membranes. Obstet. Gynecol. 84: 278, 1994.
9. Minami S., Yamoto M., Nakano R. Immunohistochemical localization of inhibin-activin subunits in hydatidiform mole and invasive mole. Obstet. Gynecol. 82: 414, 1993.
10. Petraglia F., Aguzzoli L., Gallinelli A., Florio P., Zonca M., Bendetto C., Woodruff T.K. Hypertension in pregnancy: changes in activin A maternal serum concentration. Placenta 16: 447, 1995.
11. Petraglia F., De Vita D., Gallinelli A., Aguzzoli L., Genazzani A.R., Romero R., Woodruff T.K. Abnormal concentration of maternal serum activin A in gestational diseases. J. Clin. Endocrinol. Metab. 80: 558, 1995.
12. Hussa R. Clinical applications of hCG test: tumors. In: Hussa R (Ed.), The clinical marker hCG. Praeger, New York, 1987, p 119.